These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37660465)

  • 1. Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor.
    Imai Y; Suzuki R; Wakasugi D; Matsuda D; Tanaka-Yamamoto N; Ohki Y; Mima M; Endo M; Tabata R; Matsuzawa H; Hasegawa Y; Kato S; Sugisaki M; Miyagawa H; Fujimoto N; Fukunaga T; Kato S; Takahashi T; Kakinuma H
    Bioorg Med Chem; 2023 Oct; 93():117460. PubMed ID: 37660465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach.
    Imai Y; Suzuki R; Matsuda D; Tanaka-Yamamoto N; Ohki Y; Tabata R; Kato S; Sugisaki M; Fujimoto N; Fukunaga T; Kato S; Takahashi T; Kakinuma H
    Bioorg Med Chem Lett; 2024 Jan; 97():129543. PubMed ID: 37939863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor.
    Imai Y; Wakasugi D; Suzuki R; Kato S; Sugisaki M; Mima M; Miyagawa H; Endo M; Fujimoto N; Fukunaga T; Kato S; Kuroda S; Takahashi T; Kakinuma H
    Bioorg Med Chem Lett; 2023 Jan; 79():129050. PubMed ID: 36368497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling.
    Kiyan Y; Tkachuk S; Kurselis K; Shushakova N; Stahl K; Dawodu D; Kiyan R; Chichkov B; Haller H
    Sci Rep; 2019 Sep; 9(1):13591. PubMed ID: 31537875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy.
    Buijsers B; Garsen M; de Graaf M; Bakker-van Bebber M; Guo C; Li X; van der Vlag J
    Front Pharmacol; 2023; 14():1098184. PubMed ID: 37180718
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cells.
    Cheng CC; Lee YH; Lin SP; Huangfu WC; Liu IH
    J Biomed Sci; 2014 Mar; 21(1):21. PubMed ID: 24624965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate mediates trastuzumab effect in breast cancer cells.
    Suarez ER; Paredes-Gamero EJ; Del Giglio A; Tersariol IL; Nader HB; Pinhal MA
    BMC Cancer; 2013 Oct; 13():444. PubMed ID: 24083474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel single-stranded nucleic acid aptamers against the pro-angiogenic and metastatic enzyme heparanase (HPSE1).
    Simmons SC; McKenzie EA; Harris LK; Aplin JD; Brenchley PE; Velasco-Garcia MN; Missailidis S
    PLoS One; 2012; 7(6):e37938. PubMed ID: 22719856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hpa2 Gene Cloning.
    McKenzie E
    Adv Exp Med Biol; 2020; 1221():787-805. PubMed ID: 32274738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium.
    Lever R; Rose MJ; McKenzie EA; Page CP
    Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1184-90. PubMed ID: 24740543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.
    Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
    Wu L; Davies GJ
    Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.
    Li J; Meng X; Hu J; Zhang Y; Dang Y; Wei L; Shi M
    Am J Cancer Res; 2017; 7(2):234-244. PubMed ID: 28337373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.